|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 37/02 | (2006.01) |
| (11) | Number of the document | 2487188 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12159091.3 |
| Date of filing the European patent application | 2007-10-01 | |
| (97) | Date of publication of the European application | 2012-08-15 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-08 |
| (46) | Date of publication of the claims translation | 2017-05-10 |
| (30) | Number | Date | Country code |
| 827882 P | 2006-10-02 | US | |
| 873072 P | 2006-12-05 | US | |
| 969895 P | 2007-09-04 | US |
| (72) |
Tocker, Joel, US
Peschon, Jacques J., US
Fitzpatrick, David, AU
Lim, Ai Ching, US
Mehlin, Christopher, US
Smothers, James F., US
|
| (73) |
Kirin-Amgen Inc.,
C/o Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | IL-17 receptoriaus A antigeną surišantys baltymai |
| IL-17 receptor A antigen binding proteins |
| Payment date | Validity (years) | Amount | |
| 2024-08-01 | 18 | 347.00 EUR |
| 2025-10-01 |